Cargando…
Abstract 70: High dose intravenous therapy augments complete anterior pituitary hormoanl recovery in primary autoimmune hypophysitis
Background: Glucocorticoid treatment of primary autoimmune hypophysitis (PAH) is well established; however, dose, route, and recovery predictors are not well-defined. Aims: Systematic review of published literature for use of glucocorticoids as first line of management in PAH- to analyze treatment p...
Autores principales: | Brijesh, K, Shah, Ravikumar, Memon, Saba, Patil, Virendra, Lila, Anurag, Shah, Nalini, Bandgar, Tushar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067719/ http://dx.doi.org/10.4103/2230-8210.342187 |
Ejemplares similares
-
Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
por: Diwaker, Chakra, et al.
Publicado: (2022) -
Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis
por: Krishnappa, Brijesh, et al.
Publicado: (2022) -
Abstract 58: Favourable outcomes with therapeutic glucocorticoid regimen compared to replacement glucocorticoid regimen in primary hypophysitis
por: Das, Liza, et al.
Publicado: (2022) -
Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
por: Mudalagiri, Manasa, et al.
Publicado: (2022) -
Abstract 86: Pneumo-encephalus: A rare complication following pituitary surgery
por: Nikith, Siddu
Publicado: (2022)